- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
The Cicletanine market is a segment of the cardiovascular drugs market that focuses on the treatment of hypertension. Cicletanine is a drug used to treat high blood pressure, and is often prescribed as a first-line treatment for hypertension. It works by blocking the action of certain hormones in the body, which helps to reduce blood pressure. Cicletanine is available in both generic and branded forms, and is typically taken once a day. It is also available in combination with other drugs, such as diuretics, to provide additional blood pressure control.
The Cicletanine market is highly competitive, with many pharmaceutical companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, and Sanofi. Other companies, such as Mylan and Teva, also offer generic versions of the drug. Show Less Read more